Fuchs' Endothelial Corneal Dystrophy clinical trials at UC Health
1 research study open to eligible people
open to eligible people ages 18 years and up
The objective of this study is to investigate the effect of K-321 in patients with Fuchs endothelial corneal dystrophy (FECD) after descemetorhexis.
at UC Davis UCLA